Global Drug Delivery Devices Market Research Report 2021

Global Drug Delivery Devices Market Research Report 2021

Table of Contents
1 Drug Delivery Devices Market Overview
1.1 Product Overview and Scope of Drug Delivery Devices
1.2 Drug Delivery Devices Segment by Type
1.2.1 Global Drug Delivery Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Injection type
1.2.3 Mucosal type
1.2.4 Implanted type
1.2.5 Others type
1.3 Drug Delivery Devices Segment by Application
1.3.1 Drug Delivery Devices Sales Comparison by Application: (2021-2027)
1.3.2 Pharmaceutical companies
1.3.3 Hospitals
1.3.4 Clinics
1.3.5 Other
1.4 Global Drug Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Drug Delivery Devices Revenue 2016-2027
1.4.2 Global Drug Delivery Devices Sales 2016-2027
1.4.3 Drug Delivery Devices Market Size by Region: 2016 Versus 2021 Versus 2027
2 Drug Delivery Devices Market Competition by Manufacturers
2.1 Global Drug Delivery Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global Drug Delivery Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Drug Delivery Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Drug Delivery Devices Manufacturing Sites, Area Served, Product Type
2.5 Drug Delivery Devices Market Competitive Situation and Trends
2.5.1 Drug Delivery Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Drug Delivery Devices Players Market Share by Revenue
2.5.3 Global Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug Delivery Devices Retrospective Market Scenario by Region
3.1 Global Drug Delivery Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Drug Delivery Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Drug Delivery Devices Market Facts & Figures by Country
3.3.1 North America Drug Delivery Devices Sales by Country
3.3.2 North America Drug Delivery Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Drug Delivery Devices Market Facts & Figures by Country
3.4.1 Europe Drug Delivery Devices Sales by Country
3.4.2 Europe Drug Delivery Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Drug Delivery Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Drug Delivery Devices Sales by Region
3.5.2 Asia Pacific Drug Delivery Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Drug Delivery Devices Market Facts & Figures by Country
3.6.1 Latin America Drug Delivery Devices Sales by Country
3.6.2 Latin America Drug Delivery Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Drug Delivery Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Drug Delivery Devices Sales by Country
3.7.2 Middle East and Africa Drug Delivery Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Drug Delivery Devices Historic Market Analysis by Type
4.1 Global Drug Delivery Devices Sales Market Share by Type (2016-2021)
4.2 Global Drug Delivery Devices Revenue Market Share by Type (2016-2021)
4.3 Global Drug Delivery Devices Price by Type (2016-2021)
5 Global Drug Delivery Devices Historic Market Analysis by Application
5.1 Global Drug Delivery Devices Sales Market Share by Application (2016-2021)
5.2 Global Drug Delivery Devices Revenue Market Share by Application (2016-2021)
5.3 Global Drug Delivery Devices Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Cipla
6.1.1 Cipla Corporation Information
6.1.2 Cipla Description and Business Overview
6.1.3 Cipla Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Cipla Product Portfolio
6.1.5 Cipla Recent Developments/Updates
6.2 Baxter International
6.2.1 Baxter International Corporation Information
6.2.2 Baxter International Description and Business Overview
6.2.3 Baxter International Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Baxter International Product Portfolio
6.2.5 Baxter International Recent Developments/Updates
6.3 Nipro Corporation
6.3.1 Nipro Corporation Corporation Information
6.3.2 Nipro Corporation Description and Business Overview
6.3.3 Nipro Corporation Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Nipro Corporation Product Portfolio
6.3.5 Nipro Corporation Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Roche Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Boehringer Ingelheim Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Allergan
6.6.1 Allergan Corporation Information
6.6.2 Allergan Description and Business Overview
6.6.3 Allergan Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Allergan Product Portfolio
6.6.5 Allergan Recent Developments/Updates
6.7 3M
6.6.1 3M Corporation Information
6.6.2 3M Description and Business Overview
6.6.3 3M Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 3M Product Portfolio
6.7.5 3M Recent Developments/Updates
6.8 BD
6.8.1 BD Corporation Information
6.8.2 BD Description and Business Overview
6.8.3 BD Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.8.4 BD Product Portfolio
6.8.5 BD Recent Developments/Updates
6.9 Catalent
6.9.1 Catalent Corporation Information
6.9.2 Catalent Description and Business Overview
6.9.3 Catalent Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Catalent Product Portfolio
6.9.5 Catalent Recent Developments/Updates
6.10 Bausch Health
6.10.1 Bausch Health Corporation Information
6.10.2 Bausch Health Description and Business Overview
6.10.3 Bausch Health Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Bausch Health Product Portfolio
6.10.5 Bausch Health Recent Developments/Updates
6.11 Bayer AG
6.11.1 Bayer AG Corporation Information
6.11.2 Bayer AG Drug Delivery Devices Description and Business Overview
6.11.3 Bayer AG Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Bayer AG Product Portfolio
6.11.5 Bayer AG Recent Developments/Updates
6.12 Chiesi
6.12.1 Chiesi Corporation Information
6.12.2 Chiesi Drug Delivery Devices Description and Business Overview
6.12.3 Chiesi Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Chiesi Product Portfolio
6.12.5 Chiesi Recent Developments/Updates
6.13 Phillips-Medisize
6.13.1 Phillips-Medisize Corporation Information
6.13.2 Phillips-Medisize Drug Delivery Devices Description and Business Overview
6.13.3 Phillips-Medisize Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Phillips-Medisize Product Portfolio
6.13.5 Phillips-Medisize Recent Developments/Updates
6.14 Johnson & Johnson
6.14.1 Johnson & Johnson Corporation Information
6.14.2 Johnson & Johnson Drug Delivery Devices Description and Business Overview
6.14.3 Johnson & Johnson Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Johnson & Johnson Product Portfolio
6.14.5 Johnson & Johnson Recent Developments/Updates
6.15 Shandong Weigao
6.15.1 Shandong Weigao Corporation Information
6.15.2 Shandong Weigao Drug Delivery Devices Description and Business Overview
6.15.3 Shandong Weigao Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Shandong Weigao Product Portfolio
6.15.5 Shandong Weigao Recent Developments/Updates
6.16 Pfizer
6.16.1 Pfizer Corporation Information
6.16.2 Pfizer Drug Delivery Devices Description and Business Overview
6.16.3 Pfizer Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Pfizer Product Portfolio
6.16.5 Pfizer Recent Developments/Updates
6.17 B.Braun
6.17.1 B.Braun Corporation Information
6.17.2 B.Braun Drug Delivery Devices Description and Business Overview
6.17.3 B.Braun Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.17.4 B.Braun Product Portfolio
6.17.5 B.Braun Recent Developments/Updates
6.18 Novartis AG
6.18.1 Novartis AG Corporation Information
6.18.2 Novartis AG Drug Delivery Devices Description and Business Overview
6.18.3 Novartis AG Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Novartis AG Product Portfolio
6.18.5 Novartis AG Recent Developments/Updates
6.19 Zhengkang
6.19.1 Zhengkang Corporation Information
6.19.2 Zhengkang Drug Delivery Devices Description and Business Overview
6.19.3 Zhengkang Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Zhengkang Product Portfolio
6.19.5 Zhengkang Recent Developments/Updates
6.20 Gerresheimer
6.20.1 Gerresheimer Corporation Information
6.20.2 Gerresheimer Drug Delivery Devices Description and Business Overview
6.20.3 Gerresheimer Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Gerresheimer Product Portfolio
6.20.5 Gerresheimer Recent Developments/Updates
6.21 COVIDIEN Medtronic
6.21.1 COVIDIEN Medtronic Corporation Information
6.21.2 COVIDIEN Medtronic Drug Delivery Devices Description and Business Overview
6.21.3 COVIDIEN Medtronic Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.21.4 COVIDIEN Medtronic Product Portfolio
6.21.5 COVIDIEN Medtronic Recent Developments/Updates
6.22 Schott forma vitrum
6.22.1 Schott forma vitrum Corporation Information
6.22.2 Schott forma vitrum Drug Delivery Devices Description and Business Overview
6.22.3 Schott forma vitrum Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Schott forma vitrum Product Portfolio
6.22.5 Schott forma vitrum Recent Developments/Updates
6.23 Alkermes
6.23.1 Alkermes Corporation Information
6.23.2 Alkermes Drug Delivery Devices Description and Business Overview
6.23.3 Alkermes Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Alkermes Product Portfolio
6.23.5 Alkermes Recent Developments/Updates
6.24 Skyepharma
6.24.1 Skyepharma Corporation Information
6.24.2 Skyepharma Drug Delivery Devices Description and Business Overview
6.24.3 Skyepharma Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.24.4 Skyepharma Product Portfolio
6.24.5 Skyepharma Recent Developments/Updates
7 Drug Delivery Devices Manufacturing Cost Analysis
7.1 Drug Delivery Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Drug Delivery Devices
7.4 Drug Delivery Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Drug Delivery Devices Distributors List
8.3 Drug Delivery Devices Customers
9 Drug Delivery Devices Market Dynamics
9.1 Drug Delivery Devices Industry Trends
9.2 Drug Delivery Devices Growth Drivers
9.3 Drug Delivery Devices Market Challenges
9.4 Drug Delivery Devices Market Restraints
10 Global Market Forecast
10.1 Drug Delivery Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Drug Delivery Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Drug Delivery Devices by Type (2022-2027)
10.2 Drug Delivery Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Drug Delivery Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Drug Delivery Devices by Application (2022-2027)
10.3 Drug Delivery Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Drug Delivery Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Drug Delivery Devices by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Drug Delivery Devices Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Drug Delivery Devices Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Drug Delivery Devices Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Drug Delivery Devices Covered in This Study
Table 5. Global Drug Delivery Devices Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Drug Delivery Devices Sales Share by Manufacturers (2016-2021)
Table 7. Global Drug Delivery Devices Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Drug Delivery Devices Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Drug Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Drug Delivery Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Drug Delivery Devices Product Type
Table 12. Global Drug Delivery Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Drug Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Delivery Devices as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Drug Delivery Devices Sales by Region (2016-2021) & (K Units)
Table 16. Global Drug Delivery Devices Sales Market Share by Region (2016-2021)
Table 17. Global Drug Delivery Devices Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Drug Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 19. North America Drug Delivery Devices Sales Market Share by Country (2016-2021)
Table 20. North America Drug Delivery Devices Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Drug Delivery Devices Revenue Market Share by Country (2016-2021)
Table 22. Europe Drug Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 23. Europe Drug Delivery Devices Sales Market Share by Country (2016-2021)
Table 24. Europe Drug Delivery Devices Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Drug Delivery Devices Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Drug Delivery Devices Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Drug Delivery Devices Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Drug Delivery Devices Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Drug Delivery Devices Revenue Market Share by Region (2016-2021)
Table 30. Latin America Drug Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Drug Delivery Devices Sales Market Share by Country (2016-2021)
Table 32. Latin America Drug Delivery Devices Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Drug Delivery Devices Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Drug Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Drug Delivery Devices Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Drug Delivery Devices Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Drug Delivery Devices Revenue Market Share by Country (2016-2021)
Table 38. Global Drug Delivery Devices Sales (K Units) by Type (2016-2021)
Table 39. Global Drug Delivery Devices Sales Market Share by Type (2016-2021)
Table 40. Global Drug Delivery Devices Revenue (Million US$) by Type (2016-2021)
Table 41. Global Drug Delivery Devices Revenue Share by Type (2016-2021)
Table 42. Global Drug Delivery Devices Price (USD/Unit) by Type (2016-2021)
Table 43. Global Drug Delivery Devices Sales (K Units) by Application (2016-2021)
Table 44. Global Drug Delivery Devices Sales Market Share by Application (2016-2021)
Table 45. Global Drug Delivery Devices Revenue (Million US$) by Application (2016-2021)
Table 46. Global Drug Delivery Devices Revenue Share by Application (2016-2021)
Table 47. Global Drug Delivery Devices Price (USD/Unit) by Application (2016-2021)
Table 48. Cipla Corporation Information
Table 49. Cipla Description and Business Overview
Table 50. Cipla Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Cipla Drug Delivery Devices Product
Table 52. Cipla Recent Developments/Updates
Table 53. Baxter International Corporation Information
Table 54. Baxter International Description and Business Overview
Table 55. Baxter International Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Baxter International Drug Delivery Devices Product
Table 57. Baxter International Recent Developments/Updates
Table 58. Nipro Corporation Corporation Information
Table 59. Nipro Corporation Description and Business Overview
Table 60. Nipro Corporation Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Nipro Corporation Drug Delivery Devices Product
Table 62. Nipro Corporation Recent Developments/Updates
Table 63. Roche Corporation Information
Table 64. Roche Description and Business Overview
Table 65. Roche Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Roche Drug Delivery Devices Product
Table 67. Roche Recent Developments/Updates
Table 68. Boehringer Ingelheim Corporation Information
Table 69. Boehringer Ingelheim Description and Business Overview
Table 70. Boehringer Ingelheim Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Boehringer Ingelheim Drug Delivery Devices Product
Table 72. Boehringer Ingelheim Recent Developments/Updates
Table 73. Allergan Corporation Information
Table 74. Allergan Description and Business Overview
Table 75. Allergan Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Allergan Drug Delivery Devices Product
Table 77. Allergan Recent Developments/Updates
Table 78. 3M Corporation Information
Table 79. 3M Description and Business Overview
Table 80. 3M Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. 3M Drug Delivery Devices Product
Table 82. 3M Recent Developments/Updates
Table 83. BD Corporation Information
Table 84. BD Description and Business Overview
Table 85. BD Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. BD Drug Delivery Devices Product
Table 87. BD Recent Developments/Updates
Table 88. Catalent Corporation Information
Table 89. Catalent Description and Business Overview
Table 90. Catalent Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Catalent Drug Delivery Devices Product
Table 92. Catalent Recent Developments/Updates
Table 93. Bausch Health Corporation Information
Table 94. Bausch Health Description and Business Overview
Table 95. Bausch Health Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Bausch Health Drug Delivery Devices Product
Table 97. Bausch Health Recent Developments/Updates
Table 98. Bayer AG Corporation Information
Table 99. Bayer AG Description and Business Overview
Table 100. Bayer AG Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Bayer AG Drug Delivery Devices Product
Table 102. Bayer AG Recent Developments/Updates
Table 103. Chiesi Corporation Information
Table 104. Chiesi Description and Business Overview
Table 105. Chiesi Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Chiesi Drug Delivery Devices Product
Table 107. Chiesi Recent Developments/Updates
Table 108. Phillips-Medisize Corporation Information
Table 109. Phillips-Medisize Description and Business Overview
Table 110. Phillips-Medisize Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Phillips-Medisize Drug Delivery Devices Product
Table 112. Phillips-Medisize Recent Developments/Updates
Table 113. Johnson & Johnson Corporation Information
Table 114. Johnson & Johnson Description and Business Overview
Table 115. Johnson & Johnson Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Johnson & Johnson Drug Delivery Devices Product
Table 117. Johnson & Johnson Recent Developments/Updates
Table 118. Shandong Weigao Corporation Information
Table 119. Shandong Weigao Description and Business Overview
Table 120. Shandong Weigao Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Shandong Weigao Drug Delivery Devices Product
Table 122. Shandong Weigao Recent Developments/Updates
Table 123. Pfizer Corporation Information
Table 124. Pfizer Description and Business Overview
Table 125. Pfizer Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Pfizer Drug Delivery Devices Product
Table 127. Pfizer Recent Developments/Updates
Table 128. B.Braun Corporation Information
Table 129. B.Braun Description and Business Overview
Table 130. B.Braun Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. B.Braun Drug Delivery Devices Product
Table 132. B.Braun Recent Developments/Updates
Table 133. Novartis AG Corporation Information
Table 134. Novartis AG Description and Business Overview
Table 135. Novartis AG Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Novartis AG Drug Delivery Devices Product
Table 137. Novartis AG Recent Developments/Updates
Table 138. Zhengkang Corporation Information
Table 139. Zhengkang Description and Business Overview
Table 140. Zhengkang Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Zhengkang Drug Delivery Devices Product
Table 142. Zhengkang Recent Developments/Updates
Table 143. Gerresheimer Corporation Information
Table 144. Gerresheimer Description and Business Overview
Table 145. Gerresheimer Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. Gerresheimer Drug Delivery Devices Product
Table 147. Gerresheimer Recent Developments/Updates
Table 148. COVIDIEN Medtronic Corporation Information
Table 149. COVIDIEN Medtronic Description and Business Overview
Table 150. COVIDIEN Medtronic Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 151. COVIDIEN Medtronic Drug Delivery Devices Product
Table 152. COVIDIEN Medtronic Recent Developments/Updates
Table 153. Schott forma vitrum Corporation Information
Table 154. Schott forma vitrum Description and Business Overview
Table 155. Schott forma vitrum Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 156. Schott forma vitrum Drug Delivery Devices Product
Table 157. Schott forma vitrum Recent Developments/Updates
Table 158. Alkermes Corporation Information
Table 159. Alkermes Description and Business Overview
Table 160. Alkermes Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 161. Alkermes Drug Delivery Devices Product
Table 162. Alkermes Recent Developments/Updates
Table 163. Skyepharma Corporation Information
Table 164. Skyepharma Description and Business Overview
Table 165. Skyepharma Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 166. Skyepharma Drug Delivery Devices Product
Table 167. Skyepharma Recent Developments/Updates
Table 168. Production Base and Market Concentration Rate of Raw Material
Table 169. Key Suppliers of Raw Materials
Table 170. Drug Delivery Devices Distributors List
Table 171. Drug Delivery Devices Customers List
Table 172. Drug Delivery Devices Market Trends
Table 173. Drug Delivery Devices Growth Drivers
Table 174. Drug Delivery Devices Market Restraints
Table 175. Global Drug Delivery Devices Sales Forecast by Type (2022-2027) & (K Units)
Table 176. Global Drug Delivery Devices Sales Market Share Forecast by Type (2022-2027)
Table 177. Global Drug Delivery Devices Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 178. Global Drug Delivery Devices Revenue Market Share Forecast by Type (2022-2027)
Table 179. Global Drug Delivery Devices Sales Forecast by Application (2022-2027) & (K Units)
Table 180. Global Drug Delivery Devices Sales Market Share Forecast by Application (2022-2027)
Table 181. Global Drug Delivery Devices Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 182. Global Drug Delivery Devices Revenue Market Share Forecast by Application (2022-2027)
Table 183. Global Drug Delivery Devices Sales Forecast by Region (2022-2027) & (K Units)
Table 184. Global Drug Delivery Devices Sales Market Share Forecast by Region (2022-2027)
Table 185. Global Drug Delivery Devices Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 186. Global Drug Delivery Devices Revenue Market Share Forecast by Region (2022-2027)
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drug Delivery Devices
Figure 2. Global Drug Delivery Devices Market Share by Type in 2020 & 2027
Figure 3. Injection type Product Picture
Figure 4. Mucosal type Product Picture
Figure 5. Implanted type Product Picture
Figure 6. Others type Product Picture
Figure 7. Global Drug Delivery Devices Market Share by Application in 2020 & 2027
Figure 8. Pharmaceutical companies
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Other
Figure 12. Global Drug Delivery Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Drug Delivery Devices Market Size 2016-2027 (US$ Million)
Figure 14. Global Drug Delivery Devices Sales 2016-2027 (K Units)
Figure 15. Global Drug Delivery Devices Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Drug Delivery Devices Sales Share by Manufacturers in 2020
Figure 17. Global Drug Delivery Devices Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Drug Delivery Devices Players: Market Share by Revenue in 2020
Figure 19. Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Drug Delivery Devices Sales Market Share by Region (2016-2021)
Figure 21. Global Drug Delivery Devices Sales Market Share by Region in 2020
Figure 22. Global Drug Delivery Devices Revenue Market Share by Region (2016-2021)
Figure 23. Global Drug Delivery Devices Revenue Market Share by Region in 2020
Figure 24. U.S. Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Drug Delivery Devices by Type (2016-2021)
Figure 49. Sales Market Share of Drug Delivery Devices by Application (2016-2021)
Figure 50. Sales Market Share of Drug Delivery Devices by Application in 2020
Figure 51. Revenue Share of Drug Delivery Devices by Application (2016-2021)
Figure 52. Revenue Share of Drug Delivery Devices by Application in 2020
Figure 53. Manufacturing Cost Structure of Drug Delivery Devices
Figure 54. Manufacturing Process Analysis of Drug Delivery Devices
Figure 55. Drug Delivery Devices Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pulmonary Drug Delivery Systems Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 143

According to our LPI (LP Information) latest study, the global Pulmonary Drug Delivery Systems market size was valued at US$ 2979.8 million in 2023. With growing demand in downstream market, the Pulmonary Drug Delivery Systems is forecast to a readjusted size of US$ 4016.5 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Pulmonary Drug Delivery Systems market. Pulmonary Drug Delivery Systems are expected to show s......

Global Metered Dose Inhalers Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 88

The Metered Dose Inhalers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metered Dose Inhalers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides pr......

Global Drug Delivery Devices Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151

According to our LPI (LP Information) latest study, the global Drug Delivery Devices market size was valued at US$ 40490 million in 2023. With growing demand in downstream market, the Drug Delivery Devices is forecast to a readjusted size of US$ 57290 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Drug Delivery Devices market. Drug Delivery Devices are expected to show stable growth in the future market. However......

Global Nebulizers Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Nebulizers market size was valued at US$ 844.1 million in 2023. With growing demand in downstream market, the Nebulizers is forecast to a readjusted size of US$ 1194.4 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Nebulizers market. Nebulizers are expected to show stable growth in the future market. However, product differentiation, reducing costs, ......

Global Inhalation Therapy Nebulizer Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Inhalation Therapy Nebulizer market size was valued at US$ 1111.6 million in 2023. With growing demand in downstream market, the Inhalation Therapy Nebulizer is forecast to a readjusted size of US$ 1755.2 million by 2030 with a CAGR of 6.7% during review period. The research report highlights the growth potential of the global Inhalation Therapy Nebulizer market. Inhalation Therapy Nebulizer are expected to show stable growth......

Global Medical Nebulizer Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112

According to our LPI (LP Information) latest study, the global Medical Nebulizer market size was valued at US$ 1082.4 million in 2023. With growing demand in downstream market, the Medical Nebulizer is forecast to a readjusted size of US$ 1836.1 million by 2030 with a CAGR of 7.8% during review period. The research report highlights the growth potential of the global Medical Nebulizer market. Medical Nebulizer are expected to show stable growth in the future market. However, product diff......

Global Intrathecal Pumps Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 75

According to our LPI (LP Information) latest study, the global Intrathecal Pumps market size was valued at US$ 263.7 million in 2023. With growing demand in downstream market, the Intrathecal Pumps is forecast to a readjusted size of US$ 345.7 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Intrathecal Pumps market. Intrathecal Pumps are expected to show stable growth in the future market. However, product differ......

Global Intranasal Drug Delivery Devices Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Intranasal Drug Delivery Devices market size was valued at US$ 1118.1 million in 2023. With growing demand in downstream market, the Intranasal Drug Delivery Devices is forecast to a readjusted size of US$ 2382.3 million by 2030 with a CAGR of 11.4% during review period. The research report highlights the growth potential of the global Intranasal Drug Delivery Devices market. Intranasal Drug Delivery Devices are expected to s......

Global Drug Delivery Devices Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 156

According to our (Global Info Research) latest study, the global Drug Delivery Devices market size was valued at USD 42590 million in 2023 and is forecast to a readjusted size of USD 58700 million by 2030 with a CAGR of 4.7% during review period. Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs